We are live on ! Find out more
EVOK

Evoke Pharma
EVOK

Delisted

EVOK was delisted on the 16th of December, 2025.

Back to rankings

19 hedge funds and large institutions have $4.96M invested in Evoke Pharma in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

193% more capital invested

Capital invested by funds: $1.69M → $4.96M (+$3.27M)

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

6% more funds holding

Funds holding: 18 → 19 (+1)

0.3% less ownership

Funds ownership: 5.97% → 5.67% (-0.3%)

Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$337K
2
BlackRock
BlackRock
New York
+$268K
3
Goldman Sachs
Goldman Sachs
New York
+$67.9K
4
Morgan Stanley
Morgan Stanley
New York
+$50.3K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$12K

Top Sellers

Rank Fund Capital Flow
1
SOMRS
State of Michigan Retirement System
Michigan
-$464K
2
Citadel Advisors
Citadel Advisors
Florida
-$31K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$30K
4
Victory Capital Management
Victory Capital Management
Texas
-$4K

EVOK Hedge Fund Activity: Q2 2020 in Review

19 of the 4,889 institutional investors tracked by Wall St. Rank reported a position in Evoke Pharma (EVOK) for Q2 2020, worth a combined $4.96M — up 193% from $1.69M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new EVOK positions and 3 closed out — a net gain of 1 holder — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, adding an estimated $337K. The largest seller was State of Michigan Retirement System, exiting entirely with an estimated $464K sold.

  • 19 institutional investors held Evoke Pharma (EVOK) as of Q2 2020, up from 18 in Q1 2020.
  • Funds reported $4.96M of Evoke Pharma stock for Q2 2020, up 193% quarter-over-quarter.
  • 4 funds opened new Evoke Pharma positions in Q2 2020 and 3 closed out, a net change of +1 holder.
  • The largest Evoke Pharma buyer in Q2 2020 was Vanguard Group, an estimated $337K added.
  • The largest Evoke Pharma seller in Q2 2020 was State of Michigan Retirement System, an estimated $464K sold.

Based on aggregated 13F filings for Q2 2020.